Study on MRD Prediction of Efficacy of Toripalimab in the Treatment of High-risk Recurrent Renal Carcinoma
Clinical trial NCT07657325 · RECRUITING
Trial details
- NCT number
- NCT07657325
- Sponsor
- Tianjin Medical University Second Hospital
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-04-01
- Primary completion
- 2028-02-01
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.